158 related articles for article (PubMed ID: 18262304)
1. Short-term intensive glycemic control improves vibratory sensation in type 2 diabetes.
Fujita Y; Fukushima M; Suzuki H; Taniguchi A; Nakai Y; Kuroe A; Yasuda K; Hosokawa M; Yamada Y; Inagaki N; Seino Y
Diabetes Res Clin Pract; 2008 Apr; 80(1):e16-9. PubMed ID: 18262304
[TBL] [Abstract][Full Text] [Related]
2. Use of the C64 quantitative tuning fork and the effect of niceritrol in diabetic neuropathy.
Hotta N; Sugimura K; Tsuchida I; Sano T; Koh N; Matsumae H; Sakamoto N
Clin Ther; 1994; 16(6):1007-15. PubMed ID: 7697680
[TBL] [Abstract][Full Text] [Related]
3. [Augmentation of myocardial function by improved glycemic control in patients with type 2 diabetes mellitus].
von Bibra H; Siegmund T; Hansen A; Jensen J; Schumm-Draeger PM
Dtsch Med Wochenschr; 2007 Apr; 132(14):729-34. PubMed ID: 17393343
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of fibrinolysis in poorly controlled, hospitalized type 2 diabetic patients by short-term metabolic control: association with a decrease in plasminogen activator inhibitor 1.
Aso Y; Okumura KI; Yoshida N; Tayama K; Takemura Y; Inukai T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):175-80. PubMed ID: 15127320
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
Goldberg RB; Fonseca VA; Truitt KE; Jones MR
Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
[TBL] [Abstract][Full Text] [Related]
6. Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control.
Chisalita SI; Lindström T; Eson Jennersjö P; Paulsson JF; Westermark GT; Olsson AG; Arnqvist HJ
Acta Diabetol; 2009 Mar; 46(1):35-42. PubMed ID: 18777156
[TBL] [Abstract][Full Text] [Related]
7. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
Caballero AE
J Diabetes Complications; 2009; 23(2):143-52. PubMed ID: 18413192
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
Miyazaki Y; DeFronzo RA
Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
[TBL] [Abstract][Full Text] [Related]
9. Effects of 3-month treatment with the antioxidant alpha-lipoic acid in diabetic peripheral neuropathy.
Negrişanu G; Roşu M; Bolte B; Lefter D; Dabelea D
Rom J Intern Med; 1999; 37(3):297-306. PubMed ID: 15532308
[TBL] [Abstract][Full Text] [Related]
10. The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration.
Worthley MI; Holmes AS; Willoughby SR; Kucia AM; Heresztyn T; Stewart S; Chirkov YY; Zeitz CJ; Horowitz JD
J Am Coll Cardiol; 2007 Jan; 49(3):304-10. PubMed ID: 17239711
[TBL] [Abstract][Full Text] [Related]
11. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
[TBL] [Abstract][Full Text] [Related]
12. [The effect of improved glycemic control on quality of life in patients with type I and type II diabetes].
Grzeszczak W
Wiad Lek; 2001; 54(11-12):674-83. PubMed ID: 11928556
[TBL] [Abstract][Full Text] [Related]
13. Systematic strategies for improved outcomes for the hyperglycemic hospitalized patient with diabetes mellitus.
Vasa F
Am J Cardiol; 2005 Aug; 96(4A):41E-46E. PubMed ID: 16098843
[TBL] [Abstract][Full Text] [Related]
14. Glycemic variability and its responses to intensive insulin treatment in newly diagnosed type 2 diabetes.
Zhou J; Jia W; Bao Y; Ma X; Lu W; Li H; Hu C; Xiang K
Med Sci Monit; 2008 Nov; 14(11):CR552-8. PubMed ID: 18971871
[TBL] [Abstract][Full Text] [Related]
15. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
[TBL] [Abstract][Full Text] [Related]
16. Effect of short term intensive multitherapy on carotid intima-media thickness in patients with newly diagnosed type 2 diabetes mellitus.
Guo LX; Pan Q; Wang XX; Li H; Zhang LN; Chi JM; Wang Y
Chin Med J (Engl); 2008 Apr; 121(8):687-90. PubMed ID: 18701019
[TBL] [Abstract][Full Text] [Related]
17. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
18. Extent of glycemic control in type 2 diabetes mellitus: close, but no cigar.
Lerch C; Richter B
Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):593-5. PubMed ID: 19833492
[No Abstract] [Full Text] [Related]
19. Prebeta1-HDL is elevated in the fasting state, but markedly reduced postprandially in poorly controlled type 2 diabetic patients.
Hirayama S; Ito T; Miyazaki O; Kamimura T; Hanyu O; Seino U; Ito S; Aizawa Y; Miida T
Clin Chim Acta; 2009 Mar; 401(1-2):57-62. PubMed ID: 19056371
[TBL] [Abstract][Full Text] [Related]
20. Type 2 diabetes in primary care in belgium: need for structured shared care.
Goderis G; Borgermans L; Heyrman J; Broeke CV; Grol R; Boland B; Mathieu C
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):367-72. PubMed ID: 19358093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
